NCT03372239View on ClinicalTrials.gov

Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

January 25, 2018

Study Completion Date

April 16, 2018

Conditions
Healthy
Interventions
DRUG

Indoximod base formulation

Specified dose on specified days

DRUG

Indoximod HCL (salt) formulation

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (1)

Unknown

INC Research/inVentiv Health, Toronto

Sponsors
All Listed Sponsors
lead

NewLink Genetics Corporation

INDUSTRY

NCT03372239 - Oral Bioavailability,and Food Effect Study and Single Ascending Dose PK Study in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter